Dynamic Technology Lab’s Achillion Pharmaceuticals ACHN Stock Holding History

Dynamic Technology Lab’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,815	Closed	-$40K	–	1469
2018 Q4	$40K	Buy	+24,815	New	+$70.1K	0.01%	934
2018 Q3	–	Sell	-13,178	Closed	-$37K	–	1493
2018 Q2	$37K	Buy	+13,178	New	+$44.9K	0.01%	936
2018 Q1	–	Sell	-37,171	Closed	-$108K	–	1518
2017 Q4	$108K	Buy	+37,171	New	+$135K	0.02%	937
2017 Q2	–	Sell	-32,757	Closed	-$138K	–	1451
2017 Q1	$138K	Buy	+32,757	New	+$136K	0.03%	870
2016 Q3	–	Sell	-55,521	Closed	-$433K	–	1278
2016 Q2	$433K	Buy	55,521 +40,114	+260%	+$344K	0.12%	331
2016 Q1	$119K	Buy	+15,407	New	+$113K	0.03%	824
2014 Q3	–	Sell	-15,519	Closed	-$117K	–	941
2014 Q2	$117K	Buy	+15,519	New	+$61.9K	0.06%	584

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dynamic Technology Lab's ACHN Position: Q1 2019 in Review

Dynamic Technology Lab sold out of Achillion Pharmaceuticals (ACHN) in Q1 2019, closing a stake of 24,815 shares — an estimated $40K sold.

Dynamic Technology Lab first reported a position in ACHN in Q2 2014 and held it in 7 quarters. The position peaked at $433K in Q2 2016. 110 funds tracked by Wall St. Rank hold ACHN as of Q1 2019.

Dynamic Technology Lab reported no remaining Achillion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Dynamic Technology Lab sold 24,815 Achillion Pharmaceuticals shares in Q1 2019, an estimated $40K.
Dynamic Technology Lab first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 7 quarters.
Dynamic Technology Lab's Achillion Pharmaceuticals position peaked at $433K in Q2 2016.
110 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2019.

Based on Dynamic Technology Lab's 13F filing for Q1 2019, filed 13 May 2019.